Iii J Edward Dulac

Affiliations

  • Evp, Chief Financial Officer at Intellia Therapeutics Inc. (NTLA), 2025-03-04
  • Chief Financial Officer at Fate Therapeutics Inc (FATE), 2024-03-05
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FATE $7.77 2,447 $19,013.19 101,479 2024-03-04 Filing
FATE $5.00 1,849 $9,245.00 103,926 2024-01-29 Filing
FATE $4.37 7,028 $30,712.36 105,775 2024-01-09 Filing
FATE $3.66 5,182 $18,966.12 112,803 2024-01-02 Filing
FATE $3.50 1,585 $5,547.50 117,985 2023-12-18 Filing